Manyana, Sontaga
Pillay, Melendhran
Gounder, Lilishia
Khan, Aabida
Moodley, Pravi
Naidoo, Kogieleum
Chimukangara, Benjamin
Funding for this research was provided by:
Poliomyelitis Research Foundation (21/36)
European and Developing Countries Clinical Trials Partnership (TMA2019CDF-2728)
Article History
Received: 3 June 2022
Accepted: 3 February 2023
First Online: 9 February 2023
Declarations
:
: We obtained ethics approval from the Biomedical Research Ethics Committee of the University of KwaZulu-Natal (BREC/000026/2021). Ethics approval was also obtained from the Biomedical Research Ethics Committee of the University of KwaZulu-Natal (BE419/17) for CAP103 study. All participants gave written informed consent to participate in CAP103 study, and also gave written informed consent for sample storage and re-use.
: Not applicable.
: The authors declare that they have no competing interests.